Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federico Simonetta

Showing results (21-30 of 78) with videos related to

Pageof 8
Sort By:
Cancers|December 10, 2021
AMP-Activated Protein Kinase Contributes to Apoptosis Induced by the Bcl-2 Inhibitor Venetoclax in Acute Myeloid LeukemiaNoémie Legrand, Amandine Pradier, Laury Poulain, et al.
The Journal of Infectious Diseases|March 30, 2012
Early and long-lasting alteration of effector CD45RA(-)Foxp3(high) regulatory T-cell homeostasis during HIV infectionFederico Simonetta, Camille Lecuroux, Isabelle Girault, et al.
Ejhaem|June 19, 2024
Severe anaphylaxis after chimeric antigen receptor T-cell injection: a case reportSarah Morin, Filippo Boroli, Sophie Vandenberghe-Durr, et al.
Hematological Oncology|November 8, 2023
How to integrate CD19 specific chimeric antigen receptor T cells with other CD19 targeting agents in diffuse large B-cell lymphoma?Carmen de Ramon Ortiz, Sisi Wang, Anastasios Stathis, et al.
Frontiers in Immunology|January 25, 2021
Infusion of Host-Derived Unlicensed NK Cells Improves Donor Engraftment in Non-Myeloablative Allogeneic Hematopoietic Cell TransplantationMaite Alvarez, Antonio Pierini, Federico Simonetta, et al.
Frontiers in Oncology|April 3, 2023
Real-world experience of sorafenib maintenance after allogeneic hematopoietic stem cell transplantation for FLT3-ITD AML reveals high rates of toxicity-related treatment interruptionSarah Morin, Federica Giannotti, Anne-Claire Mamez, et al.
International Review of Cell and Molecular Biology|July 7, 2022
Killers on the loose: Immunotherapeutic strategies to improve NK cell-based therapy for cancer treatmentCordelia Dunai, Erik Ames, Maria C Ochoa, et al.
Frontiers in Immunology|June 4, 2019
Dynamics of Expression of Programmed Cell Death Protein-1 (PD-1) on T Cells After Allogeneic Hematopoietic Stem Cell TransplantationFederico Simonetta, Amandine Pradier, Carine Bosshard, et al.
Frontiers in Immunology|March 3, 2020
Indirect Impact of PD-1/PD-L1 Blockade on a Murine Model of NK Cell ExhaustionMaite Alvarez, Federico Simonetta, Jeanette Baker, et al.
Blood Advances|June 8, 2021
Activation of natural killer T cells enhances the function of regulatory T-cell therapy in suppressing murine GVHDToshihito Hirai, Po-Yu Lin, Federico Simonetta, et al.
Pageof 8

Showing results (21-30 of 78) with videos related to

Sort By:
Pageof 8
Cancers|December 10, 2021
AMP-Activated Protein Kinase Contributes to Apoptosis Induced by the Bcl-2 Inhibitor Venetoclax in Acute Myeloid LeukemiaNoémie Legrand, Amandine Pradier, Laury Poulain, et al.
The Journal of Infectious Diseases|March 30, 2012
Early and long-lasting alteration of effector CD45RA(-)Foxp3(high) regulatory T-cell homeostasis during HIV infectionFederico Simonetta, Camille Lecuroux, Isabelle Girault, et al.
Ejhaem|June 19, 2024
Severe anaphylaxis after chimeric antigen receptor T-cell injection: a case reportSarah Morin, Filippo Boroli, Sophie Vandenberghe-Durr, et al.
Hematological Oncology|November 8, 2023
How to integrate CD19 specific chimeric antigen receptor T cells with other CD19 targeting agents in diffuse large B-cell lymphoma?Carmen de Ramon Ortiz, Sisi Wang, Anastasios Stathis, et al.
Frontiers in Immunology|January 25, 2021
Infusion of Host-Derived Unlicensed NK Cells Improves Donor Engraftment in Non-Myeloablative Allogeneic Hematopoietic Cell TransplantationMaite Alvarez, Antonio Pierini, Federico Simonetta, et al.
Frontiers in Oncology|April 3, 2023
Real-world experience of sorafenib maintenance after allogeneic hematopoietic stem cell transplantation for FLT3-ITD AML reveals high rates of toxicity-related treatment interruptionSarah Morin, Federica Giannotti, Anne-Claire Mamez, et al.
International Review of Cell and Molecular Biology|July 7, 2022
Killers on the loose: Immunotherapeutic strategies to improve NK cell-based therapy for cancer treatmentCordelia Dunai, Erik Ames, Maria C Ochoa, et al.
Frontiers in Immunology|June 4, 2019
Dynamics of Expression of Programmed Cell Death Protein-1 (PD-1) on T Cells After Allogeneic Hematopoietic Stem Cell TransplantationFederico Simonetta, Amandine Pradier, Carine Bosshard, et al.
Frontiers in Immunology|March 3, 2020
Indirect Impact of PD-1/PD-L1 Blockade on a Murine Model of NK Cell ExhaustionMaite Alvarez, Federico Simonetta, Jeanette Baker, et al.
Blood Advances|June 8, 2021
Activation of natural killer T cells enhances the function of regulatory T-cell therapy in suppressing murine GVHDToshihito Hirai, Po-Yu Lin, Federico Simonetta, et al.
Pageof 8